Ju In Park, Jiwook Ryu, Chang Kyu Park, Bong Jin Park, Bong Arm Rhee, Seok Keun Choi
{"title":"聚四氟乙烯对特发性三叉神经痛的Meckel穴压迫治疗:作为一种改良手术技术的可能性","authors":"Ju In Park, Jiwook Ryu, Chang Kyu Park, Bong Jin Park, Bong Arm Rhee, Seok Keun Choi","doi":"10.52662/jksfn.2023.00059","DOIUrl":null,"url":null,"abstract":"Objective: We analyzed the clinical outcomes of Meckel’s cave compression with Teflon (Rhee’s method) as a new modified and additional surgical technique for trigeminal neuralgia (TN).Methods: Between March 1996 and December 2014, out of 78 patients who were treated with microvascular decompression (MVD) or partial sensory root rhizotomy, 28 patients additionally underwent Meckel’s cave compression with Teflon. The mean age at initial treatment was 54.3 years (range: 40–69 years). The mean duration from onset to operation was 70.5 months (range: 5–360 months) and the mean follow-up period was 26 months (range: 1–77 months). Results: Fifteen patients (53.6%) had facial pain in the V2/V3 distribution. The offending or associating vessel was the superior cerebellar artery in four patients (14.3%), the superior petrosal vein in six (21.4%), the anterior inferior cerebellar artery in two (7.1%), multiple vessels in nine (32.1%), and miscellaneous arteries or veins in six (21.4%). One patient (3.6%) had no offending vessel, and seven patients were had no definite offending vessels that contacted the trigeminal root entry zone. Meckel’s cave compression with Teflon was applied to all patients: 10 (35.7%) in combination with MVD, one (3.6%) with partial rhizotomy, and 17 (60.7%) with both MVD and partial rhizotomy. TN was relieved in 26 patients (92.9%) and symptoms recurred in three patients (pain-free rate: 82.1%). The complication rate of this method appeared to be similar to other treatment procedures. Conclusion: Meckel’s cave compression with Teflon may be a safe and useful additional treatment procedure for TN.","PeriodicalId":34983,"journal":{"name":"Korean Journal of Dermatology","volume":"19 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Meckel’s cave compression with Teflon for the treatment of idiopathic trigeminal neuralgia: its possibility as a modified surgical technique\",\"authors\":\"Ju In Park, Jiwook Ryu, Chang Kyu Park, Bong Jin Park, Bong Arm Rhee, Seok Keun Choi\",\"doi\":\"10.52662/jksfn.2023.00059\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: We analyzed the clinical outcomes of Meckel’s cave compression with Teflon (Rhee’s method) as a new modified and additional surgical technique for trigeminal neuralgia (TN).Methods: Between March 1996 and December 2014, out of 78 patients who were treated with microvascular decompression (MVD) or partial sensory root rhizotomy, 28 patients additionally underwent Meckel’s cave compression with Teflon. The mean age at initial treatment was 54.3 years (range: 40–69 years). The mean duration from onset to operation was 70.5 months (range: 5–360 months) and the mean follow-up period was 26 months (range: 1–77 months). Results: Fifteen patients (53.6%) had facial pain in the V2/V3 distribution. The offending or associating vessel was the superior cerebellar artery in four patients (14.3%), the superior petrosal vein in six (21.4%), the anterior inferior cerebellar artery in two (7.1%), multiple vessels in nine (32.1%), and miscellaneous arteries or veins in six (21.4%). One patient (3.6%) had no offending vessel, and seven patients were had no definite offending vessels that contacted the trigeminal root entry zone. Meckel’s cave compression with Teflon was applied to all patients: 10 (35.7%) in combination with MVD, one (3.6%) with partial rhizotomy, and 17 (60.7%) with both MVD and partial rhizotomy. TN was relieved in 26 patients (92.9%) and symptoms recurred in three patients (pain-free rate: 82.1%). The complication rate of this method appeared to be similar to other treatment procedures. Conclusion: Meckel’s cave compression with Teflon may be a safe and useful additional treatment procedure for TN.\",\"PeriodicalId\":34983,\"journal\":{\"name\":\"Korean Journal of Dermatology\",\"volume\":\"19 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Korean Journal of Dermatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52662/jksfn.2023.00059\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean Journal of Dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52662/jksfn.2023.00059","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Meckel’s cave compression with Teflon for the treatment of idiopathic trigeminal neuralgia: its possibility as a modified surgical technique
Objective: We analyzed the clinical outcomes of Meckel’s cave compression with Teflon (Rhee’s method) as a new modified and additional surgical technique for trigeminal neuralgia (TN).Methods: Between March 1996 and December 2014, out of 78 patients who were treated with microvascular decompression (MVD) or partial sensory root rhizotomy, 28 patients additionally underwent Meckel’s cave compression with Teflon. The mean age at initial treatment was 54.3 years (range: 40–69 years). The mean duration from onset to operation was 70.5 months (range: 5–360 months) and the mean follow-up period was 26 months (range: 1–77 months). Results: Fifteen patients (53.6%) had facial pain in the V2/V3 distribution. The offending or associating vessel was the superior cerebellar artery in four patients (14.3%), the superior petrosal vein in six (21.4%), the anterior inferior cerebellar artery in two (7.1%), multiple vessels in nine (32.1%), and miscellaneous arteries or veins in six (21.4%). One patient (3.6%) had no offending vessel, and seven patients were had no definite offending vessels that contacted the trigeminal root entry zone. Meckel’s cave compression with Teflon was applied to all patients: 10 (35.7%) in combination with MVD, one (3.6%) with partial rhizotomy, and 17 (60.7%) with both MVD and partial rhizotomy. TN was relieved in 26 patients (92.9%) and symptoms recurred in three patients (pain-free rate: 82.1%). The complication rate of this method appeared to be similar to other treatment procedures. Conclusion: Meckel’s cave compression with Teflon may be a safe and useful additional treatment procedure for TN.